Cas 1228277-01-7,benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine

1228277-01-7

Post Buying Request

Basic information

Product Name: benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine
Synonyms: benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine
CAS NO:1228277-01-7
Molecular Formula:
Molecular Weight: 524.062
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine(CAS DataBase Reference)
NIST Chemistry Reference: benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine(1228277-01-7)
EPA Substance Registry System: benzyl-(2-(5-(2,4-bisbenzyloxy-5-chlorophenyl)-2H-pyrazol-3-yl)ethyl)amine(1228277-01-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1228277-01-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1228277-01-7 Suppliers

Recommended suppliers

1228277-01-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1228277-01-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,8,2,7 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1228277-01:
(9*1)+(8*2)+(7*2)+(6*8)+(5*2)+(4*7)+(3*7)+(2*0)+(1*1)=147
147 % 10 = 7
So 1228277-01-7 is a valid CAS Registry Number.

1228277-01-7Upstream product

1228276-98-9 1-benzyl-3-(2,4-bisbenzyloxy-5-chlorobenzoyl)piperidin-4-one

1228277-01-7Downstream Products

1228277-01-7Relevant academic research and scientific papers

BICYCLIC PYRAZOLE AND ISOXAZOLE DERIVATIVES AS ANTITUMOR AND ANTINEURODEGENERATIVE AGENTS

-

Page/Page column 30-31, (2010/06/17)

Bicyclic pyrazole and isoxazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases mediated by HSP90 protein, like cancer and neurodegenerative disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1228277-01-7